Skip to main content
Medicine LibreTexts

6.4.11: 11. Histological Classification of Salivary Neoplasms

  • Page ID
    18333
  • \( \newcommand{\vecs}[1]{\overset { \scriptstyle \rightharpoonup} {\mathbf{#1}} } \)

    \( \newcommand{\vecd}[1]{\overset{-\!-\!\rightharpoonup}{\vphantom{a}\smash {#1}}} \)

    \( \newcommand{\id}{\mathrm{id}}\) \( \newcommand{\Span}{\mathrm{span}}\)

    ( \newcommand{\kernel}{\mathrm{null}\,}\) \( \newcommand{\range}{\mathrm{range}\,}\)

    \( \newcommand{\RealPart}{\mathrm{Re}}\) \( \newcommand{\ImaginaryPart}{\mathrm{Im}}\)

    \( \newcommand{\Argument}{\mathrm{Arg}}\) \( \newcommand{\norm}[1]{\| #1 \|}\)

    \( \newcommand{\inner}[2]{\langle #1, #2 \rangle}\)

    \( \newcommand{\Span}{\mathrm{span}}\)

    \( \newcommand{\id}{\mathrm{id}}\)

    \( \newcommand{\Span}{\mathrm{span}}\)

    \( \newcommand{\kernel}{\mathrm{null}\,}\)

    \( \newcommand{\range}{\mathrm{range}\,}\)

    \( \newcommand{\RealPart}{\mathrm{Re}}\)

    \( \newcommand{\ImaginaryPart}{\mathrm{Im}}\)

    \( \newcommand{\Argument}{\mathrm{Arg}}\)

    \( \newcommand{\norm}[1]{\| #1 \|}\)

    \( \newcommand{\inner}[2]{\langle #1, #2 \rangle}\)

    \( \newcommand{\Span}{\mathrm{span}}\) \( \newcommand{\AA}{\unicode[.8,0]{x212B}}\)

    \( \newcommand{\vectorA}[1]{\vec{#1}}      % arrow\)

    \( \newcommand{\vectorAt}[1]{\vec{\text{#1}}}      % arrow\)

    \( \newcommand{\vectorB}[1]{\overset { \scriptstyle \rightharpoonup} {\mathbf{#1}} } \)

    \( \newcommand{\vectorC}[1]{\textbf{#1}} \)

    \( \newcommand{\vectorD}[1]{\overrightarrow{#1}} \)

    \( \newcommand{\vectorDt}[1]{\overrightarrow{\text{#1}}} \)

    \( \newcommand{\vectE}[1]{\overset{-\!-\!\rightharpoonup}{\vphantom{a}\smash{\mathbf {#1}}}} \)

    \( \newcommand{\vecs}[1]{\overset { \scriptstyle \rightharpoonup} {\mathbf{#1}} } \)

    \( \newcommand{\vecd}[1]{\overset{-\!-\!\rightharpoonup}{\vphantom{a}\smash {#1}}} \)

    Malignant epithelial tumours

    • Mucoepidermoid carcinoma
    • Adenoid cystic carcinoma
    • Acinic cell carcinoma
    • Polymorphous adenocarcinoma
    • Clear cell carcinoma
    • Basal cell adenocarcinoma
    • Intraductal carcinoma
    • Adenocarcinoma, NOS
    • Salivary duct carcinoma
    • Myoepithelial carcinoma
    • Epithelial-myoepithelial carcinoma
    • Carcinoma ex pleomorphic adenoma
    • Secretory carcinoma
    • Sebaceous adenocarcinoma
    • Carcinosarcoma
    • Poorly differentiated carcinoma
    • Undifferentiated carcinoma
    • Large cell neuroendocrine carcinoma
    • Small cell neuroendocrine carcinoma
    • Lymphoepithelial carcinoma
    • Squamous cell carcinoma
    • Oncocytic carcinoma
    • Uncertain malignant potential
    • Sialoblastoma

    Benign tumours

    • Pleomorphic adenoma
    • Myoepithelioma
    • Basal cell adenoma
    • Warthin tumour
    • Oncocytoma
    • Lymphadenoma
    • Cystadenoma
    • Sialadenoma papilliferum
    • Ductal papillomas
    • Sebaceous adenoma
    • Canalicular adenoma and other ductal adenomas

    Non-neoplastic epithelial lesions

    • Sclerosing polycystic adenosis
    • Nodular oncocytic hyperplasia
    • Lymphoepithelial sialaedenitis
    • Intercalated duct hyperplasia

    Benign soft tissue lesions

    • Haemangioma
    • Lipoma/sialolipoma
    • Nodular fasciitis

    Haematolymphoid tumours

    • Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)

    Secondary malignancies